Skip to main content

David Aluja Gonzalez

Institutions of which they are part

Research technician
Cardiovascular Diseases
Vall Hebron Institut de Recerca

David Aluja Gonzalez

Institutions of which they are part

Research technician
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Efecto de la reposición de hierro sobre el remodelado ventricular después de la oclusi´pon coronaria transitoria en un modelo animal de ferropenia inducida por dieta

IP: José Antonio Barrabés Riu
Collaborators: Ignacio Ferreira González, David Aluja Gonzalez, Sara Delgado Tomás, Laura Castellote Bellés, Javier Inserte Igual
Funding agency: -Sociedad Española de Cardiologia
Funding: 15000
Reference: SEC/FEC-INV-BAS 23/11
Duration: 26/10/2023 - 31/12/2027

Paper de la reprogramació del metabolisme d'aminoàcids i la desregulació de les calpaïnes en l'activació dels fibroblasts i la fibrosi miocàrdica difusa en la insuficiència cardíaca

IP: Javier Inserte Igual
Collaborators: Ignacio Ferreira González, José Antonio Barrabés Riu, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, David Aluja Gonzalez, Sara Delgado Tomás
Funding agency: Fundació La Marató de TV3
Funding: 150000
Reference: 202321-31
Duration: 11/03/2024 - 10/03/2027

Role of amino acid metabolism reprogramming and calpain deregulation in fibroblasts activation and diffuse myocardial fibrosis in heart failure

IP: Javier Inserte Igual
Collaborators: José Antonio Barrabés Riu, David Aluja Gonzalez, Juan Garrido Oliver, Elisabet Miro Casas, Sara Delgado Tomás, Bou Teen, Diana
Funding agency: Instituto de Salud Carlos III
Funding: 152500
Reference: PI23/00068
Duration: 01/01/2024 - 31/12/2026

Daño mitocondrial por estrés dicarbonílico como impulsor de la senescencia: papel de los senolíticos en la protección del corazón durante el envejecimiento.

IP: Marisol Ruiz Meana
Collaborators: Rafael Rodríguez Lecoq, David Aluja Gonzalez, Elisabet Miro Casas, Bou Teen, Diana
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI22/00513
Duration: 01/01/2023 - 31/12/2025

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

David Soler Segovia

David Soler Segovia

Predoctoral researcher
Pneumology
Read more
Susana  Manrique Muñoz

Susana Manrique Muñoz

Predoctoral researcher
Maternal and Fetal Medicine
Read more
Maira Cortes Espriu

Maira Cortes Espriu

Cardiovascular Diseases
Read more
Silvia Aneas Posadas

Silvia Aneas Posadas

Epidemiology and Public Health
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.